Vancomycin Efficacy in Response to Dysbiosis in Atypical Colitis

Clinical trial NCT07646223 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07646223
Sponsor: Tampere University Hospital
Status: NOT_YET_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Ulcerative Colitis (UC)Primary Sclerosing Cholangitis (PSC)Pediatric Inflammatory Bowel Diseases

Start date: 2026-08-01
Primary completion: 2032-12-31
Enrollment: 140

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.